Related Experiment Video

Updated: Aug 25, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumors

Adrian Dubs, Emanuel Jacky, Rolf Stahel

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |March 17, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
    13:25

    Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

    Published on: May 15, 2021

    Related Experiment Videos

    Last Updated: Aug 25, 2026

    Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
    09:52

    Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

    Published on: March 16, 2018

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
    13:25

    Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

    Published on: May 15, 2021

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

    Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

    Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

    Articles linked to this work by shared authors, journal, and citation graph.

    Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

    Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial.

    JAMA oncology·2026

    Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland.

    Swiss medical weekly·2025

    Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial.

    Lung cancer (Amsterdam, Netherlands)·2025

    Pertuzumab as second‑ or later‑line therapy for human epidermal growth factor receptor 2‑positive metastatic breast cancer: A clinical experience.

    Molecular and clinical oncology·2023

    Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma.

    JTO clinical and research reports·2022

    P-Loop/αC-Helix Compressing Mutations and Exon 20 Insertions in EGFR-Mutant NSCLC: A Rapidly Evolving Therapeutic Landscape.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early-Stage Breast Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    [Evaluation of tolerability and cognitive safety of trospium chloride in the treatment of overactive bladder: a systematic review and meta-analysis].

    Urologiia (Moscow, Russia : 1999)·2026

    [Innovative approaches to carboxyperitoneum creation: experimental developments and clinical perspectives].

    Urologiia (Moscow, Russia : 1999)·2026

    [Risk factors of postoperative urinary retention in patients with intradural extramedullary spinal cord tumors].

    Urologiia (Moscow, Russia : 1999)·2026

    [Complex therapy of chronic bacterial prostatitis using the immunomodulatory drug sodium aminodihydrophthalazinedione].

    Urologiia (Moscow, Russia : 1999)·2026

    Real-world treatment patterns and outcomes in metastatic clear cell renal cell carcinoma following immune checkpoint inhibitor progression (2018-2023).

    The oncologist·2026

    Bronchial stump re-resection for carcinoid tumor recurrence after left pneumonectomy: Case report.

    Turk gogus kalp damar cerrahisi dergisi·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us